Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shockwave or laser: which zaps plantar fasciitis pain best?

NCT ID NCT07672327

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two non-invasive treatments—extracorporeal shock wave therapy and high-intensity laser therapy—for chronic plantar fasciitis, a common cause of heel pain. Sixty adults will receive one of the treatments plus standard physical therapy. Researchers will measure pain, foot function, and muscle strength to see which approach works better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Extracorporeal shock wave therapy and high-intensity laser therapy
What this could lead to
If successful, this could show which non-invasive treatment works better for reducing heel pain and improving foot function in people with chronic plantar fasciitis.
What could go wrong
This is a small, early-stage trial with only 60 participants. Results may not apply to everyone, and neither treatment may prove clearly better than standard physical therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Patients will be included according to the diagnostic criteria for plantar fasciitis of the American physical therapy association (APTA) (Martin et al., 2014). This criterion includes pain in medial sole and heel of foot: most pronounced in initial steps after a period of inactivity, it also worsens after prolonged weight bearing, pain during palpation and compression of proximal plantar fascia, limited range of motion in active and passive ankle dorsiflexion, positive windlass test. 2\. Patients will be referred from an orthopedic surgeon with confirmed diagnosis of plantar fasciitis (Bidoki et al., 2024). 3\. Patients with chronic plantar fasciitis (Duration of patient's symptoms will be more than three months) (Riaz et al., 2023). 4\. Patients' age will range from 18 to 45 years (Bidoki et al., 2024). 5. Both genders (Riaz et al., 2023). 6. Localized non radiating foot pain with an NPRS more than 5 on the first step in the morning (Riaz et al., 2023). Exclusion Criteria: * Patients will be excluded if they present any of the following criteria 1. History of previous surgery of plantar fasciitis (Riaz et al., 2023). 2. History of previous corticosteroid injections (Bidoki et al., 2024). 3. History of heel pain due to previous trauma or calcaneus stress fracture in the last 3 months (Bidoki et al., 2024). 4. History of previous lumbar spine surgery (Bidoki et al., 2024). 5. History of rheumatologic disease (rheumatoid arthritis, diffuse idiopathic skeletal hyperostosis, systemic lupus erythematosus, gout, Sjogren disease, enthesopathy, etc…) (Bidoki et al., 2024). 6. Pregnancy, pacemaker fitted or bleeding disorders (Bidoki et al., 2024). 7. Wounds, infections or tumors in the treatment area (Bidoki et al., 2024).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Plantar fasciitis, chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mecca

    Mecca, Mecca Region, 24211, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.